New drug cocktail aims to tame resistant blood cancer
NCT ID NCT04835129
Summary
This study is testing whether a combination of four drugs is safe and effective for adults with multiple myeloma that has come back or stopped responding to at least two prior treatments. The goal is to see if this four-drug mix works better than similar combinations with fewer drugs. Participants receive the drugs in 28-day cycles and are closely monitored for their response and any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
The University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.